View Michael Lisanti, MD-PhD, FRSA, FRSB, FRSC’s profile (He/Him) • 1st
Professor & Chair, Translational Medicine, at The University of SalfordCongratulations !!!
陇山陇西郡
宁静纯我心 感得事物人 写朴实清新. 闲书闲话养闲心,闲笔闲写记闲人;人生无虞懂珍惜，以沫相濡字字真。
正文
I am pleased to join Oncotarget as an Editor-in-Chief this June, 2024.
This is a great journal that was started in 2010. The journal has published impactful research over the years by leaders in the field. The journal is indexed in PubMed, PMC, and MEDLINE and has its own digital archive. Oncotarget follows the guidelines based on the recommendations of the Committee on Publication Ethics (COPE). The journal conducts author interviews and promotes published research through press releases.
https://lnkd.in/e3pnxfQr
https://lnkd.in/eJ63zVeM
https://lnkd.in/e7PeqzKF
https://lnkd.in/eFyTKPGK
I’d like to invite my colleagues to submit manuscripts and would particularly encourage translational research, progress in precision oncology, therapy for cancer’s hallmarks, drug resistance, plasticity, epigenetics, microbiome, environmental carcinogenesis, intersection of behavior and biology of cancer, cancer immunotherapy, functional precision medicine, molecular imaging, theranostics, stem cells, liquid biopsy and tumor heterogeneity.
Problems such as CNS primary or metastatic cancers, blood brain barrier research, viruses and cancer, cell cycle and cell death, biomarkers (predictive, prognostic, and pharmacodynamic), pro-drugs, nanotherapeutics, drug metabolism, novel omics, tumor dormancy and early detection are of interest.
Technology enabling of progress using AI, statistics and novel clinical trial designs, new devices for diagnostics and therapeutics, single cell profiling, 3-D visualization of TME, single molecule visualization are relevant areas of interest.
We welcome clinical case reports, case series, commentaries, reviews, clinical trial results, and Meeting Reports.
Please feel free to reach out to me directly if you have any questions or manuscripts we might consider.
I hope you will have a positive experience in sharing your contributions of new knowledge and/or expertise in an efficient manner with Oncotarget.
I look forward to having positive impact in this new role working with Mikhail Blagosklonny, MD, PhD (Misha) @Blagosklonny and Andrei Gudkov, PhD at Roswell Park Comprehensive Cancer Center
I previously served as the founding Editor-in-Chief of Cancer Biology and Therapy for 18 years from 2001-2019.
https://lnkd.in/e94AgCBk
https://lnkd.in/epRJ4N77
The Warren Alpert Medical School of Brown University Brown University @BrownUCancer WIN Consortium in cancer personalized medicine hashtagLegorretaCancerCenter hashtageldeirylab American Cancer Society American Cancer Society Cancer Action Network (ACS CAN) OncoAlert OncoDaily AACI (Association of American Cancer Institutes) National Cancer Institute (NCI) The National Institutes of Health National Academy of Inventors The Cancer Letter
This is a great journal that was started in 2010. The journal has published impactful research over the years by leaders in the field. The journal is indexed in PubMed, PMC, and MEDLINE and has its own digital archive. Oncotarget follows the guidelines based on the recommendations of the Committee on Publication Ethics (COPE). The journal conducts author interviews and promotes published research through press releases.
https://lnkd.in/e3pnxfQr
https://lnkd.in/eJ63zVeM
https://lnkd.in/e7PeqzKF
https://lnkd.in/eFyTKPGK
I’d like to invite my colleagues to submit manuscripts and would particularly encourage translational research, progress in precision oncology, therapy for cancer’s hallmarks, drug resistance, plasticity, epigenetics, microbiome, environmental carcinogenesis, intersection of behavior and biology of cancer, cancer immunotherapy, functional precision medicine, molecular imaging, theranostics, stem cells, liquid biopsy and tumor heterogeneity.
Problems such as CNS primary or metastatic cancers, blood brain barrier research, viruses and cancer, cell cycle and cell death, biomarkers (predictive, prognostic, and pharmacodynamic), pro-drugs, nanotherapeutics, drug metabolism, novel omics, tumor dormancy and early detection are of interest.
Technology enabling of progress using AI, statistics and novel clinical trial designs, new devices for diagnostics and therapeutics, single cell profiling, 3-D visualization of TME, single molecule visualization are relevant areas of interest.
We welcome clinical case reports, case series, commentaries, reviews, clinical trial results, and Meeting Reports.
Please feel free to reach out to me directly if you have any questions or manuscripts we might consider.
I hope you will have a positive experience in sharing your contributions of new knowledge and/or expertise in an efficient manner with Oncotarget.
I look forward to having positive impact in this new role working with Mikhail Blagosklonny, MD, PhD (Misha) @Blagosklonny and Andrei Gudkov, PhD at Roswell Park Comprehensive Cancer Center
I previously served as the founding Editor-in-Chief of Cancer Biology and Therapy for 18 years from 2001-2019.
https://lnkd.in/e94AgCBk
https://lnkd.in/epRJ4N77
The Warren Alpert Medical School of Brown University Brown University @BrownUCancer WIN Consortium in cancer personalized medicine hashtagLegorretaCancerCenter hashtageldeirylab American Cancer Society American Cancer Society Cancer Action Network (ACS CAN) OncoAlert OncoDaily AACI (Association of American Cancer Institutes) National Cancer Institute (NCI) The National Institutes of Health National Academy of Inventors The Cancer Letter
View Khalid El Bairi’s profile • 2nd
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 AwardeeA lot of research integrity concerns in this journal as well!
7 Replies on Khalid El Bairi’s comment
View Wafik S. El-Deiry, MD, PhD, FACP’s profile (He/Him)Author
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RIKhalid El Bairi feel free to share any concerns you currently have directly with me wafik@brown.edu
View Khalid El Bairi’s profile • 2nd
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 Awardee
View Wafik S. El-Deiry, MD, PhD, FACP’s profile (He/Him)Author
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RIKhalid El Bairi this is from at least 6 years ago while the journal was competing with other top journals. I believe the journal was maliciously targeted at the time and has put this behind them. It is fully listed at present after fighting back. I said to communicate current concerns.
View Wafik S. El-Deiry, MD, PhD, FACP’s profile (He/Him)Author
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RIKhalid El Bairi also, feel free to submit your own scholarly work on research integrity to our journal.
View Khalid El Bairi’s profile • 2nd
Working for global oncology and research integrity. Fascinated by ovarian cancer and biomarkers. Columnist for @ASCO | #LINO23 Alumnus | 2023 African Cancer Leaders Institute Fellow | ASCO IDEA 2024 AwardeeDoes Oncotarget waives the APCs for authors from LMICs ? Thanks
View Wafik S. El-Deiry, MD, PhD, FACP’s profile (He/Him)Author
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RI
View Rossella Rota’s profile • 2nd
PI, Bambino Gesù Children’s Hospital, Rome, ItalyI completely agree
View Anupam Agarwal, MD, MPH’s profile • 2nd
Senior Biotech Executive| Cardiac safety| Gene Therapy| AI| Angel InvestorCongratulations on joining Oncotarget as the Editor-in-Chief, Dr. El-Deiry! I wish you great success in this new role and look forward to the valuable contributions you and your team will bring to the field.
View Jeanie Magdalena Gatewood’s profile (She/Her) • 2nd
Clinical Research Solutions Strategist | Doctoral ResearcherCongratulations Wafik - I’m especially interested in the AI and translation research space(s) - and have thought provoking data regarding pancreatic cancer with brain metastasis - co-developed with my colleagues Dr. Susan H. and Derek Cridebring, PhD. Will be in touch
View Miguel Bronchud’s profile • 2nd
Co-Founder & Advisory Board at Regenerative Medicine SolutionsCongratulations Wafik. Good & traditionally independent scientific medical journal. Your experienced opinion and expertise will no doubt help it to become even better.
View Amit K Dash, DVM, Ph.D., M.V.Sc (Clinical Biochemistry)’s profile (He/Him) • 2nd
Cellular and Molecular Biologist #PhD|Veterinary Clinical #Biochemist #DVM I Human #ProstateCancer 3D #Organoid and 2D #celllines | #Androgenreceptor biology |Trained in #Diverse DisciplinesMany congratulations Dr Wafik S. El-Deiry, MD, PhD, FACP
View John Tarantino’s profile • 2nd
Senior Counsel Adler Pollock & Sheehan PC & CEO IYLON Precision Oncology LLC TEDx Speaker Motivational Speaker Leadership Speaker Legal Ethics Speaker Philanthropy Speaker Community Engagement SpeakerCongratulations
View Emile Y.’s profile • 2nd
Chief Medical Officer, Oncology Biotech/CROVery well deserved, Wafik!
View Dr. S. Karthik Kumar’s profile • 2nd
Scientist: Apollo Hospitals Educational and Research Foundation| Founding member: Indian Extracellular Vesicles Society| Author: Scientific | Youtuber: Health Care|Congratulations Prof., Well deserved
View Amanda R. Ferraro’s profile • 2nd
Cancer Patient Advocate•TEDx Speaker•2x Cancer Survivor•Freelance Blogger•Keynote Speaker•Healthcare Influencer•Best-Selling Author(edited)
Congratulations! This is an amazing achievement!
View Ajaz Bhat’s profile • 2nd
Research Scientist at Sidra MedicineCongratulations. The journal will achieve heights under your leadership
View Saif Afridi’s profile • 2nd
Postdoc Research Fellow at Guanzhou women and children medical centercongratulation
View Devrim Gozuacik’s profile • 2nd
Distinguished Research Professor at Koç University School of MedicineCongratulations Dear Wafik. All the best wishes
View Rakesh Pathak’s profile • 2nd
Assistant Professor at IISER BerhampurCongratulations
View Rossella Rota’s profile • 2nd
PI, Bambino Gesù Children’s Hospital, Rome, ItalyGreat journal
View Mala Talekar’s profile (She/Her) • 2nd
Vice President Clinical Development @ Verismo Therapeutics | Cell Therapy Expert | Pediatric Hematologist-OncologistCongratulations!
View Dr E. Shyam P. Reddy’s profile • 2nd
GCC Distinguished Cancer Scholar, Professor and Director, Cancer Biology Program, Department of OB/GYN, Morehouse School of Medicine, Atlanta, Ga 30310Congrats!
评论
目前还没有任何评论
登录后才可评论.
